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Shiga toxin producing Escherichia coli (STEC) cause gastrointestinal illnesses. To 
investigate the occurrence of STEC among Kenyan dromedaries, E. coli isolated 
from 163 dromedaries were screened for stx1 and stx2. STEC strains were isolated 
and serotyped. Isolates were subjected to PCR for the subtyping of stx genes and for 
the detection of eae and ehx. Whole genome sequencing (WGS) was carried out to 
detect further virulence genes and to determine the multilocus sequence types 
(MLST). Antimicrobial resistance profiles were determined by disk diffusion. 
STEC was isolated from 20 (12.3%) of the samples. Thereof, nine (45%) isolates 
were STEC O156:H25, three (15%) isolates typed STEC O43:H2. The remaining 
isolates occurred as single serotypes or were O non-typeable. Eleven (55%) of the 
isolates harboured stx2a, nine (45%) eae, and 14 (70%) ehx, respectively. WGS 
revealed the presence of iss in 16 (80%), subAB in four (20%) and astA in two (10%) 
of the isolates, Furthermore, espA, tccP, nleA, nleB, tccP, and tir were found 
exclusively among STEC O156:H25. 
Eleven different sequence types (ST) were detected. The most prominent was 
ST300/ST5343, which comprised STEC O156:H25. All STEC isolates were pan 
susceptible. The results indicate that dromedary camels in Kenya may be reservoirs 
of STEC, including serotypes associated to disease in humans. STEC in camels may 
represent a health hazard for humans with close contact or to consumers of camel 
derived foodstuffs. 
 




Shiga toxin-produzierende Escherichia coli (STEC) verursachen gastrointestinale 
Krankheiten. Um das Auftreten von STEC in kenianischen Kamelen zu untersuchen, 
wurden E. coli von 163 Kamelen auf stx1 und stx2 getestet. STEC Stämme wurden 
isoliert und serotypisiert. Mittels PCR wurden die stx-Gene subtypisiert und eae und 
ehx nachgewiesen. Whole genome sequencing (WGS) wurde durchgeführt, um 
weitere Virulenzgene zu detektieren und die Multilocus-Sequenztypen zu definieren. 
Antimikrobielle Resistenzprofile wurden mittels Disk Diffusion ermittelt.  
STEC wurden aus 20 (12.3%) der Proben isoliert. Davon waren neun (45%) STEC 
O156:H25, drei (15%) STEC O43:H2. Die übrigen Isolate waren Einzelfälle oder O-
untypisierbar. Elf (55%) Isolate bargen stx2a, neun (45%) eae, und 14 (70%) ehx. 
WGS ermittelte die Präsenz von iss in 16 (80%), subAB in vier (20%) und astA in 
zwei (10%) Isolaten. Weiter wurden espA, tccP, nleA, nleB, tccP, und tir nur in den 
zu STEC O156:H25 gehörenden Isolaten detektiert. 
Elf verschiedene Sequenztypen wurden detektiert. Der häufigste war 
ST300/ST5343, welcher STEC O156:H25 enthält. Alle STEC Isolate waren 
pansensibel. Diese Resultate lassen darauf schliessen, dass die kenianischen 
Kamele potentielle STEC-Reservoire sind. Einschliesslich potentiell 
humanpathogener Serotypen. STEC in Kamelen könnten ein Gesundheitsrisiko für 
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Shiga toxin producing Escherichia coli (STEC) cause gastrointestinal illnesses 
including non-bloody or bloody diarrhoea, haemorrhagic colitis (HC), and the 
haemolytic uremic syndrome (HUS). To investigate the occurrence of STEC among 
grazing dromedaries from Kenya, E. coli isolated from fecal matter collected from 
163 dromedaries on a large ranch were screened for the presence of stx1 and stx2. 
STEC strains were isolated and serotyped. Isolates were subjected to PCR for the 
subtyping of stx genes and for the detection of eae and ehx. In addition, whole 
genome sequencing (WGS) was carried out to detect further virulence genes and to 
determine the multilocus sequence types (MLST). Antimicrobial resistance profiles 
were determined by disk diffusion. 
STEC was isolated from 20 (12.3%) of the fecal samples. Thereof, nine (45%) 
isolates were STEC O156:H25, three (15%) isolates typed STEC O43:H2. The 
remaining isolates occurred as single serotypes or were O non-typeable. Eleven 
(55%) of the isolates harboured stx2a, nine (45%) eae, and 14 (70%) ehx, 
respectively. WGS revealed the presence of iss in 16 (80%), subAB in four (20%) 
and astA in two (10%) of the isolates, Furthermore, espA, tccP, nleA, nleB, tccP, and 
tir were found exclusively among STEC O156:H25. 
Eleven different sequence types (ST) were detected. The most prominent was 
ST300/ST5343, which comprised STEC O156:H25. All STEC isolates were pan 
susceptible to a panel of 16 antimicrobial agents. Overall, the results indicate that 
dromedary camels in Kenya may be reservoirs of STEC, including serotypes 
possessing virulence markers associated to disease in humans, such as STEC 
O156:H25. STEC in camels may represent a health hazard for humans with close 
contact to camels or to consumers of camel derived foodstuffs, such as 




In East Africa, the one-humped Arabian camel (Camelus dromedarius) is an 
important livestock species particularly well adapted to semi-arid and arid 
environments [1]. In Kenya, the husbandry of semi-domesticated dromedaries is a 
traditional livelihood of the nomadic pastoralists, with milk constituting an important 
nutrient source and income asset [2]. 
Kenya as a country relies heavily on wildlife tourism [3]. In the Laikipia county in 
central Kenya which is known for its remarkable abundance of wildlife, livestock 
husbandry and tourism are alternatives to land cultivation [4, 5]. Dromedary camel 
herds have become established both in pastoral communities and on large ranches 
where they are used for wildlife safaris and to produce milk for consumption and 
trade [1]. 
Camels in sub-saharan Africa reportedly represent a reservoir for a variety of 
potentially zoonotic diseases and pathogens, including Coxiella burnetii [6], Brucella 
spp. [7], Hepatitis E Virus [8], and Middle East respiratory syndrome coronavirus [9]. 
By contrast, Shiga toxin producing Escherichia coli (STEC), which may cause 
gastrointestinal illnesses including non-bloody or bloody diarrhoea, haemorrhagic 
colitis (HC), and the haemolytic uremic syndrome (HUS) [10], has rarely been 
described in camels. STEC causes an estimated 2,801,000 acute illnesses annually 
and poses a significant health burden worldwide [11, 12]. 
The distinguishing feature of STEC is the presence of one or more Shiga toxin (stx) 
genes which include two major forms, stx1 and stx2 and subtypes thereof [13]. Other 
major virulence genes that influence the pathogenic potential of STEC include the 
intimin gene eae, and the enterohemolysin gene ehx [14, 15]. Additional virulence 
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factors such as espA, nleA, iss or subAB are also frequently associated with disease 
in humans [16, 17]. 
STEC O157:H7 is the serotype most frequently associated with severe clinical 
outcomes, nonetheless, non-O157 STEC serogroups, including O26, O103, O111, 
and O145, are also recognized for their pathogenic potential [18]. 
Wild and domestic animals, including cattle, sheep, goats and deer represent the 
most important reservoirs of STEC [12]. Examples of healthy domestic animals that 
are known to be hosts of human pathogenic STEC serotypes are given in Table 1. 
The consumption of contaminated water, meat, raw milk, raw milk products and 
produce, and the direct contact with farm animals have been identified as important 
routes of transmission [12, 19]. A better understanding of the occurrence of STEC 
among animal reservoirs is essential to provide a framework for developing 
approaches to reduce the burden of STEC related disease worldwide.  
So far, E. coli O157:H7 and STEC O157:H7 was isolated from meat and feces of 
camels in Iran, respectively [20, 21]. By contrast, several studies have reported the 
absence of STEC in camels in the United Arab Emirats and Eastern Africa [22, 23, 
24]. 
This study aimed to update the current understanding on the occurrence of STEC in 
camels in Eastern Africa by screening fecal samples of a herd of healthy animals 
kept under extensive husbandry systems on a ranch in Laikipia, Kenya, and to 






Material and Methods 
 
Sample collection. Fecal samples of 163 healthy dromedary camels (117 females, 
45 males and one of unknown gender) located in a ranch in the northern Laikipia 
county in Kenya were collected during January and February 2017. The camels were 
extensively kept, they shared their pasture with game and cattle. Fecal matter was 
collected by rectal palpation using one glove per animal. Samples were placed in 
sterile containers, cooled for transport and frozen at -80°C. 
The sample collection was performed in strict accordance with the Kenyan legislation 
for animal experimentation and were approved by the institutional animal care and 
use committee (IACUC reference number 2014.08). Since 1993, the International 
Livestock Research Institute (ILRI) in Kenya has complied voluntarily with the United 
Kingdom's Animals (Scientific Procedures) Act 1986 that contains guidelines and 
codes of practice for the housing and care of animals used in scientific procedures. 
Screening for stx by PCR. Each fecal sample was enriched at a 1:10 ratio in 
Enterobacteriaceae enrichment (EE) broth (Becton, Dickinson, Heidelberg, 
Germany) for 24 h at 37°C. One loopful of each of the enrichment cultures was 
cultured on sheep blood agar (Difco™ Columbia Blood Agar Base EH; Becton 
Dickinson AG, Allschwil, Switzerland) using the streak plate technique. The resulting 
colonies were washed off with 2 ml 0.85% NaCl and DNA was extracted by a 
standard lysis protocol. Screening for stx1 and stx2 genes was performed by real-
time PCR (LightCycler R 2.0 Instrument, Roche Diagnostics Corporation, 
Indianapolis, IN, USA) using the QuantiFast Multiplex PCR Kit (Qiagen, 
Hombrechtikon, Switzerland) according to the guidelines of the European Union 
Reference Laboratory (EURL) [25]. 
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Recovery of STEC. In the event of a stx positive PCR result, one loopful each of the 
enrichment broth was streaked onto on sheep blood agar (DifcoTM Columbia Blood 
Agar Base EH; Becton Dickinson AG, Allschwil, Switzerland) and onto RAPID’E. coli 
Agar (BioRad, Basel, Switzerland) to obtain single colonies of E. coli.  
From each plate, individual colonies were picked and suspended in 0.5 ml NaCl 
0.85%. Isolates that were confirmed to possess stx (stx1and/or stx2) by real-time 
PCR were subcultured on sheep blood agar and the presence of stx was confirmed 
using the Assurance GDS® for Shiga Toxin Genes (Bio Control Systems, Bellevue, 
WA, USA). From plates yielding more than one stx positive colony, one isolate was 
randomly chosen for subsequent characterization.  
Serotyping and molecular typing of stx, eae and ehx genes. Isolates were 
serotyped using the E. coli SeroGenoTyping AS-1 Kit (Alere Technologies, Jena, 
Germany).  The determination of stx1 subtypes (stx1a, stx1c, stx1d) and stx2 
subtypes (stx2a, stx2b, stx2c, stx2d, stx2e, stx2g) was performed by conventional 
PCR amplification [13]. Screening for eae, and ehx was performed by real-time PCR 
according to the guidelines of the EURL [26]. 
Whole genome sequencing. Genomic DNA libraries were prepared using the 
NexteraTM DNA Flex Library Preparation Kit following the manufacturer’s protocol 
(Illumina, San Diego, CA, USA). Libraries were loaded on a 300-cycle, 2 × 150 bp 
paired-end read cartridge (Illumina MiniSeq High Output Reagent Kit) and run on a 
MiniSeq Illumina sequencer (Illumina). The Spades assembler v3.12 [27] was used 
to assemble the reads with using the option “--careful”. The spades output was 
filtered for size > 1000 bp and coverage > 25-fold resulting in the final assemblies 
that were submitted to NCBI GenBank.  
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The sequence reads were used to run analysis in the Advanced Research 
Infrastructure for Experimentation in genomics (ARIES) public Galaxy server 
(https://w3.iss.it/site/aries/), i.e. quality control, assembly, virulence gene analysis, 
Shiga-toxin analysis, and serotyping. 
To assess the genetic relatedness of the isolates, core genome multilocus sequence 
typing (cgMLST) was carried out using Ridom Seq-Sphere Software (version 4.1.9, 
available at http://www.ridom.de/seqsphere/cgmlst/). The MLST schemes “Warwick” 
and “Pasteur” were used for MLST-typing, and the Enterobase Escherichia/Shigella 
v1 scheme (http://enterobase.warwick.ac.uk) for cgMLST typing. Assembled 
genomes were blasted against the reference database using standard settings and 
the option “ignore missing values pairwise” and “Discard genomes with > 3% missing 
genes” were used for typing. Trees were visualised using the minimal spanning tree 
option in seqsphere. 
Antibiotic resistance profiles. Antimicrobial susceptibility testing was performed 
using the disk-diffusion method and the antibiotics ampicillin (AM), amoxicillin-
clavulanic acid (AMC), cefazolin (CZ), cefotaxime (CTX), cefepime (FEP), nalidixic 
acid (NA), ciprofloxacin (CIP), gentamicin (GM), kanamycin (K), streptomycin (S), 
sulfamethoxazole/trimethoprim (SXT), fosfomycin (FOS), azithromycin (AZM), 
nitrofurantoin (F/M), chloramphenicol (C) and tetracycline (T) (Becton Dickinson, 
Heidelberg, Germany). Results were interpreted according to Clinical and Laboratory 






Results and discussion 
 
In sub-Saharan Africa, little information is available on the epidemiology of STEC in 
humans, food and animals, and current knowledge of STEC sources needs to be 
improved [12]. Data on the occurrence and the characteristics of STEC in African 
camels is limited. This study provides evidence for the fecal carriage of STEC among 
dromedary camels located on a ranch in Laikipia Kenya. The restriction to one farm 
in Kenya is a limitation of this study and may have led to bias associated with camels 
from one herd only. In order to obtain a wider picture, analyses of feces from camels 
on other farms and other regions in Kenya would be required. For this investigation, 
a total of 163 fecal swabs were obtained. Thereof, 53 (32.5%) tested positive for stx 
by real-time PCR. STEC was recovered from 20 of the stx positive samples, 
amounting to 12.3% of all fecal samples. Overall, fecal carriage of STEC was 
confirmed for 14.5% (17 of a total of 117) of the female camels and 6.7% (3 of 45) of 
the male camels (Table 2). 
The serotypes and virulence genotypes of the STEC isolates are summarized in 
Table 2. The most frequent serotypes included nine (45% of the isolates) STEC 
O156:H25 isolates and three (15%) O43:H2 isolates. The remaining strains occurred 
as single serotypes or were O non-typeable (Table 2). STEC O156:H25 has been 
described as a persistent colonizer of the bovine gut [29] and has also been linked to 
human infection in Germany and Switzerland [30, 31] (Table 1). By contrast, STEC 
O43:H2 is a rare serotype, but has been detected in beef in West Africa [32]. 
Further, various stx subtypes were detected among the isolates, including stx2a 
which is associated with severe disease in STEC infected humans [33]. The stx2a 
gene was found in a total of 11 (55%) of the isolates, including the nine STEC 
 14 
O156:H25 strains, and the STEC O8:H49 and STEC Ont:H7 isolates, respectively 
(Table 2). The intimin gene eae was detected in nine (45%) isolates, all belonging to 
serotype O156:H25 (Table 2). While eae is one of the most prominent virulence 
factors contributing to pathogenesis, many STEC feature other virulence genes that 
may enhance their pathogenic potential, such as enterohaemorrhagic E. coli 
haemolysin ehx [15, 30]. In this study, ehx was detected by PCR in fourteen (70%) of 
the isolates (Table 2).  
Furthermore, we used WGS to provide additional information on the virulence of the 
analysed STEC. Table 2 shows the presence or absence of a selection of virulence 
genes that predict severe disease in humans, including espA, tccP, nleA, nleB and tir 
(de Boer et al., 2015). Other virulence factors included in Table 2 are iss, which 
encodes an increased serum survival protein and is associated with non-bloody 
diarrhoea as well as extra-intestinal pathogenic infections [34], subAB, which is an 
emerging pathogenic factor among eae negative human pathogenic STEC isolates 
[17], and astA encoding a heat-stable enterotoxin EAST1 that is found mostly in 
enterohaemorrhagic and enteroaggregative E. coli [35]. The complete ARIES 
analysis reports on the virulotypes of the 20 sequenced strains are available upon 
request. 
Taken together, espA, tccP, nleA, nleB and tir were detected exclusively among the 
nine STEC O156:H25 isolates, while iss was identified in 16 (80%), and subAB in 
four (20%) of the isolates, respectively (Table 2). A minority of two strains (10%) 
possessed astA (Table 2). Although all STEC can conceivably cause diarrhoea, the 
risk and severity of infection is linked to the presence of virulence factors, in 
particular stx2a and eae [12]. Our results show that although 45% of the STEC 
isolated from camel feces are not highly pathogenic according to their virulence 
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factor profiles, the majority (55%) is associated with stx2a, and STEC O156:H25 
isolates in particular, exhibit a virulotype that suggests a potential health risk.  
Using the Pasteur scheme, four different sequence types (ST) were identified among 
14 isolates (Table 2). Using the Warwick scheme, 11 different STs were identified 
(Table 2). Of the nine STEC O156:H25 isolates, eight grouped in the sequence type 
ST300 and ST5334, which differ by one nucleotide in the gyrB gene, indicating close 
phylogenetic relationship of the isolates. Similarly, the three STEC O43:H2 isolates 
were assigned to ST937 and ST6275 which differ by one nucleotide in fumC. Two 
STEC Ont:H20 possessed ST5759. All other isolates belonged to singly occurring 
STs (Table 2). Accordingly, cgMLST using Ridom SeqSphere+ software divided the 
strains into distinct clusters that comprised the STEC O156:H25 isolates, the STEC 
O43:H2 isolates, and the Ont:H20 isolates, respectively, while the remaining strains 
did not reveal close phylogenetic relationship (Figure 1). 







The data from our study suggest that dromedary camels are a reservoir of human 
pathogenic STEC. While none of the fecal samples contained STEC O157:H7 or 
other non-O157 STEC serogroups frequently associated with severe clinical 
outcomes such as bloody diarrhoea, HC, or HUS, the majority of the isolates 
harboured stx2a, and the STEC O156:H25 isolates harboured eae, ehx, and other 
virulence factors often associated with disease in humans. Their occurrence in fecal 
samples from camels may represent a threat to humans, especially to those who live 
in long-term close contact with camels and consume raw camel milk. 
 
Nucleotide sequences 









This work was partly supported by the University of Zurich and the Swiss Federal 
Office of Public Health, Division communicable Disease. Additional funds were 
received from the German ministry of Economic Cooperation (Contract No. 
 17 
81195004). Anne Liljander was supported by the Centre for International Migration 





[1] Schwartz, H.J., M. Dioli. The one-humped camel (Camelus dromedarius) in 
eastern Africa. A pictorial guide to diseases, health care, and management. 1st 
ed. Berlin, 1992.  
[2] Benka, V. Human-wildlife conflict, interspecies disease, and justice in a wild-life 
rich region in Kenya. University of Michigan. Master’s thesis. Available at 
https://deepblue.lib.umich.edu/bitstream/handle/2027.42/96190/benka%20thesi
s%20final.pdf?sequence=1. Accessed 29 Nov 2018. 
[3] Valle, E., M.N. Yobesia. Economic contribution of tourism in Kenya. Tourism 
Analysis. 2009;14:401-4. 
[4] Kinnaird, M.F., T.G. O’brien. Effects of private‐land use, livestock management, 
and human tolerance on diversity, distribution, and abundance of large African 
mammals. Conserv Biol. 2012;26:1026-39. 
[5] Sundaresan, S.R., C. Riginos. Lessons learned from biodiversity conservation 
in the private lands of Laikipia, Kenya. Great Plains Res. (2010). 17-27. 
Available at https://www.jstor.org/stable/23782172. Accessed 28 Nov 2018. 
[6] DePuy, W., V. Benka, A. Massey, S.L. Deem, M. Kinnaird, T. O’Brien et al. Q 
fever risk across a dynamic, heterogeneous landscape in Laikipia County, 
Kenya. EcoHealth.. 2014;11:429-33. 
[7] Ducrotoy, M., W.J. Bertu, G. Matope, S. Cadmus, R. Conde-Álvarez, A.M. Gusi 
et al. Brucellosis in sub-saharan Africa: current challenges for management, 
diagnosis and control. Acta Trop. 2017;165:179-93. 
[8] Rasche, A., M. Saqib, A.M. Liljander, S. Bornstein, A. Zohaib, S. Renneker et 
al. Hepatitis E virus infection in dromedaries, north and east Africa, United Arab 
Emirates, and Pakistan, 1983-2015. Emerg Infect Dis. 2016;22:1249-52. 
 19 
[9] Jores, J. Middle East respiratory syndrome-coronavirus in camels: an overview 
for Sub-Saharan and North Africa. Evidence on Demand, UK. 2015. 
DOI=http://dx.doi.org/10.12774/eod_cr.july2015.joresj. 
[10] Karch, H., P.I. Tarr, M. Bielaszewska. Enterohaemorrhagic Escherichia coli in 
human medicine. Int J Med Microbiol. 2005;295:405-418. 
DOI=10.1016/j.ijmm.2005.06.009. 
[11] Majowicz, S. E., Scallan, E., Jones-Bitton, A., Sargeant, J. M., Stapleton, J., 
Angulo, F. J. et al. Global incidence of human Shiga toxin–producing 
Escherichia coli infections and deaths: A systematic review and knowledge 
synthesis. Foodborne Pathog. Dis. 2014;11:447-55. 
DOI=10.1089/fpd.2013.1704 
[12] FAO (Food and Agriculture Organization of the United Nations), WHO (World 
Health Organization). Shiga Toxin-Producing Escherichia coli (STEC) and food: 
Attribution, characterization, and monitoring: Report. FAO; Rome, WHO; 
Geneva, 2018.  
[13] Scheutz, F., L.D. Teel, L. Beutin, D. Piérard, G. Buvens, H. Karch et al. 
Multicenter evaluation of a sequence-based protocol for subtyping Shiga toxins 
and standardizing Stx nomenclature. J Clin Microbiol. 2012;50:2951-63. 
DOI=10.1128/JCM.00860-12. 
[14] Kaper, J.B., J.P. Nataro, H.L. Mobley. Pathogenic Escherichia coli. Nat Rev 
Microbiol. 2004;2:123-140. DOI=10.1038/nrmicro818. 
[15] Schmidt, H., L. Beutin, H. Karch. Molecular analysis of the plasmid-encoded 
hemolysin of Escherichia coli O157:H7 strain EDL 933. Infect Immun. 
1995;63:1055-61. 
[16] de Boer, R.F., M. Ferdous, A. Ott, H.R. Scheper, G.J. Wisselink, M.E. Heck et 
 20 
al. Assessing the public health risk of Shiga-toxin producing Escherichia coli 
using a rapid diagnostic screening algorithm. J Clin Microbiol. 2015 53:1588 –
98.  DOI=10.1128/JCM.03590-14. 
[17] Paton, A.W., P. Srimanote, U.M. Talbot, H. Wang, J.C. Paton. A new family of 
potent AB(5) cytotoxins produced by Shiga toxigenic Escherichia coli. J Exp 
Med. 2004;200:35-46. 
[18] EFSA (European Food Safety Authority). The European Union summary report 
on trends and sources of zoonoses, zoonotic agents and food-borne outbreaks 
in 2016. EFSA Journal (2017);15(12):5077, 228 pp. 
[19] Karmali, M. A. Factors in the emergence of serious human infections 
associated with highly pathogenic strains of Shiga toxin-producing Escherichia 
coli. Int J Med Microbiol. 2018; 308:1067-1072. DOI= 
10.1016/j.ijmm.2018.08.005. 
[20] Hajian, S., E. Rahimi, H. Mommtaz. A 3-year study of Escherichia coli O157: 
H7 in cattle, camel, sheep, goat, chicken and beef minced meat. Proc Internat 
Conf Food Eng Biotechnol (IPCBEE’11); 2011; Singapore. IACSIT Press. 
[21] Salehi, T.Z., A. Tonelli, A. Mazza, H. Staji, P. Badagliacca, I.A. Tamai et al. 
Genetic characterization of Escherichia coli O157: H7 strains isolated from the 
one-humped camel (Camelus dromedarius) by using microarray DNA 
technology. Mol Biotechnol. 2012;51:283-88. 
[22] El-Sayed, A., S. Ahmed, W. Awad. Do camels (Camelus dromedarius) play an 
epidemiological role in the spread of Shiga toxin producing Escherichia coli 
(STEC) infection? Trop Anim Health Prod. 2008;40:469-73. 
[23] Moore, J.E., M. McCalmont, J. Xu, G. Nation, A.H. Tinson, L. Crothers et al. P 
Prevalence of faecal pathogens in calves of racing camels (Camelus 
 21 
dromedarius) in the United Arab Emirates. Trop Anim Health Prod. 
2002;34:283-87. 
[24] Tabatabaei, S., T.Z. Salehi, M.A. Badouei, I.A. Tamai, V. Akbarinejad, R. 
Kazempoor et al. Prevalence of Shiga toxin-producing and enteropathogenic 
Escherichia coli in slaughtered camels in Iran. Small Rumin Res. 2013;113:297-
300. 
[25] EURL (European Union Reference Laboratory). 2013a. Identification and 
characterization of Verocytotoxin-producing Escherichia coli (VTEC) by PCR 
amplification of the main virulence genes. EU-RL VTEC_Method_01_Rev_0. 
Available online at: http://old.iss.it/vtec/index.php?lang=2&tipo=3. Accessed 28 
Nov 2018. 
[26] EURL (European Union Reference Laboratory). 2013b. Identification and 
characterization of Verocytotoxin-producing Escherichia coli (VTEC) by real 
time PCR amplification of the main virulence genes and the genes associated 
with the serogroups mainly associated with severe human infections. EU-RL 
VTEC_Method_02_Rev 0. Available online at: 
http://old.iss.it/vtec/index.php?lang=2&tipo=3. Accessed 28 Nov 2018.  
[27] Bankevich, A., S. Nurk, D. Antipov, A.A. Gurevich, M. Dvorkin, A.S. Kulikov et 
al. SPAdes: a new genome assembly algorithm and its applications to single-
cell sequencing. J Comput Biol. 2012;19:455-77. 
[28] CLSI (Clinical and Laboratory Standards Institute). Performance standards for 
antimicrobial susceptibility testing. 27th ed. CLSI supplement M100S. Wayne, 
2017. 
[29] Barth, S.A., C. Menge, I. Eichhorn, T. Semmler, L.H. Wieler, D. Pickard et al. 
The accessory genome of Shiga toxin-producing Escherichia coli defines a 
 22 
persistent colonization type in cattle. Appl Environ Microbiol. 2016;82:5455-64. 
[30] Beutin, L., G. Krause, S. Zimmermann, S. Kaulfuss, K. Gleier. Characterization 
of Shiga toxin-producing Escherichia coli strains isolated from human patients 
in Germany over a 3-year period. J Clin Microbiol. 2004;42:1099-1108. 
[31] Fierz, L., N. Cernela, E. Hauser, M. Nüesch-Inderbinen, R. Stephan. 
Characteristics of Shigatoxin-producing Escherichia coli strains isolated during 
2010-2014 from human infections in Switzerland. Front Microbiol. 2017;8:1471. 
DOI=10.3389/fmicb.2017.01471. 
[32] Martikainen, O., A. Kagambega, I.J. Bonkoungou, N. Barro, A. Siitonen, K. 
Haukka. Characterization of shigatoxigenic Escherichia coli strains from 
Burkina Faso. Foodborne Path Dis. 2012;9:1015-21. 
[33] Fuller, C.A., C.A. Pellino, M.J. Flagler, J.E. Strasser, A.A. Weiss. Shiga toxin 
subtypes display dramatic differences in potency. Infect Immun. 2011;79:1329-
37. 
[34] Matussek, A., C. Jernberg, I.M. Einemo, S. Monecke, R. Ehricht, I. Engelmann 
et al. Genetic makeup of Shiga toxin-producing Escherichia coli in relation to 
clinical symptoms and duration of shedding: a microarray analysis of isolates 
from Swedish children. Eur J Clin Microbiol Infect Dis. 2017;36:1433-41. 
[35] Maluta, R.P., J.L. Leite, T.C.G. Rojas, I.C.A. Scaletsky, E.A.L. Guastalli, M.D.C. 
Ramos et al. Variants of astA gene among extra-intestinal Escherichia coli of 
human and avian origin. FEMS Microbiol Lett. 2017;3646, fnw285. 
DOI=10.1093/femsle/fnw285. 
[36] Doane, C. A., Pangloli, P., Richards, H. A., Mount, J. R., Golden, D. A., 
Draughon, F. A. Occurrence of Escherichia coli O157:H7 in diverse farm 
environments. J Food Prot. 2007: 70: 6-10. 
 23 
[37] Persad, A. K. LeJeune, J. T. Animal reservoirs of Shiga toxin-producing 
Escherichia coli. Microbiol Spectr. 2014;2:231-44. 
DOI=10.1128/microbiolspec.EHEC-0027-2014. 
[38] Kang, E., Hwang, S. Y., Kwon, K. H., Kim, K. Y., Kim, J. H., Park, Y. H. 
Prevalence and characteristics of Shiga toxin-producing Escherichia coli 
(STEC) from cattle in Korea between 2010 and 2011. J Vet Sci. 2014;15: 369-
79. DOI=10.4142/jvs.2014.15.3.369. 
[39] Mainga, A. O., Cenci‐Goga, B. T., Malahlela, M. N., Tshuma, T., Kalake, A., 
Karama, M. Occurrence and characterization of seven major Shiga toxin‐
producing Escherichia coli serotypes from healthy cattle on cow–calf operations 
in South Africa. Zoonoses Public Health. 2018;65:777-89. 
DOI=10.1111/zph.12491. 
[40] Beutin, L., Geier, D., Steinrück, H., Zimmermann, S., Scheutz, F. Prevalence 
and some properties of Verotoxin (Shiga-like toxin)-producing Escherichia coli 
in seven different species of healthy domestic animals. J Cin Microbiol. 1993; 
31: 2483-8. DOI=0095-1137/93/092483-06$02.00/0. 
[41] Orden, J. A., Domínguez-Bernal, G., de la Fuente, R., Carrión, J. Subtilase 
cytotoxin-encoding subAB2 variants in Verotoxin-producing Escherichia coli 
strains isolated from goats and sheep. Res Vet Sci. 2016;105: 74-6. DOI= 
10.1016/j.rvsc.2016.01.017. 
[42] Cortés, C., De la Fuente, R., Blanco, J., Blanco, M., Blanco, J. E., Dhabi, G. et 
al. Serotypes, virulence genes and intimin types of Verotoxin-producing 
Escherichia coli and enteropathogenic E. coli isolated from healthy dairy goats 
in spain. Vet Microbiol. 2005;110: 67-76. DOI=10.1016/j.vetmic.2005.06.009. 
 24 
[43] Brandal, L. T., Sekse, C., Lindstedt, B.-A., Sunde, M., Løbersli, I., Urdahl, A. M. 
et al. Norwegian sheep are an important reservoir for human-pathogenic 






Table 1: Examples of healthy (semi)-domestic animals as hosts of Shiga toxin 
producing Escherichia coli (STEC) serotypes associated with disease in humans. 
 
Animal STEC serotype(s) Reference(s) 
Camels O157:H7, O156:H25 [21], this study 
Cattle O157:H7, O156:H25, O8:H19, O26:H2, 
O26:H8, O26:H11, O26:H19, O26:H21, 
O45:H2, O103:H2, O103:H21, O121:H8, 
O145:H2, O145:H8, O145:H28, O146:H21  
[29, 36, 37, 38, 39, 40]  
Chicken O157:H7 [36, 37]  
Goats O146:H21, O82:H8, O128:H2 [40, 41, 42]  
Sheep O157:H7, O26:H11, O146:H21, O128:H2 [37, 40, 41, 43]  
Swine O157:H7 [36, 37]  
Turkeys O157:H7 [36] 
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Table 2: Characteristics of Shiga toxin producing Escherichia coli (STEC) isolated from feces of camels from Kenya. 
 












GenBank       
accession no. 
    
C59 F O8:H19  stx1a - + - - + - - - - -  201 294 RJDD00000000 
C102 F O8:H49  stx2a - + - - + - - - - -  111 nd RJDT00000000 
C139 F O43:H2  stx1c - - - - + - - - - -  937 363 RJDN00000000 
C119 F O43:H2  stx1a - - - - + - - - - +  6275 363 RJDS00000000 
C160 F O43:H2  stx1c - - - - + - - - - +  6275 363 RJDK00000000 
C34 F O44:H18  
stx1a, 
stx2c 
- + - - + - - - - +  6507 nd 
RJDG00000000 
C21 F O117:H12  stx1a - - - - + - - - - -  101 nd RJDJ00000000 
C22 F O150:H8  stx1c - + + - - - - - - +  906 303 RJDI00000000 
C12 F O156:H25  stx2a + + - + + + + + - -  300 591 RJDR00000000 
C15 F O156:H25  stx2a + + - + + + + - + -  300 591 RJDM00000000 
C16 F O156:H25  stx2a + + - - - - - - - -  300 591 RJDL00000000 
C25 F O156:H25  stx2a + + - + + + + + + -  300 591 RJDH00000000  
C43 F O156:H25  stx2a + + - + - + + - + -  300 591 RJDF00000000 
C62 F O156:H25  stx2a + + - + + + + - + -  300 591 RJDC00000000 
C85 F O156:H25  stx2a + + - + + + + - + -  300 591 RJDB00000000 
C129 M O156:H25  stx2a + + - + + + + - + -  300 591 RJDP00000000 
C101 M O156:H25  stx2a + + + + + + + + + -  5343 591 RJDU00000000 
C127 F Ont:H7  
stx1a, 
stx2a 
- + - - - - - - - -  1308 nd 
RJDQ00000000 
C56 M Ont:H20  stx1c - - - - + - - - - -  5759 nd RJDE00000000 
C131 F Ont:H20   stx1c - - - - + - - - - -   5759 nd RJDO00000000 
 
 27 
astA, gene encoding enteroaggregative heat-stable toxin; eae, intimin gene; ehx, enterohemolysin gene; espA, gene encoding LEE-associated secreted translocator 
protein; iss, gene encoding increased serum survival protein; MLST, multilocus sequence type; nd, not defined; nle, genes encoding non-LEE-encoded factors; ST, 
sequence type; subAB, subtilase cytotoxin gene; tccP, gene encoding Tir cytoskeleton coupling protein; tir, gene encoding translocated intimin receptor; +, the gene is 




Phylogenetic relationship of 20 Shiga toxin producing Escherichia coli (STEC) 
isolated from camel feces based on their multilocus sequence type (MLST) allelic 
profiles. The minimum spanning tree was generated using SeqSphere (Ridom 
GmbH). Numbers in the lines indicate the number of allele differences between 
isolates. The size of each circle reflects the number of isolates allocated to an 
individual sequence type (ST). The colours of the circles represent STs according to 
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